Never before has it been so difficult for the Pharmaceutical industry to engage with Healthcare Professionals (HCPs); yet never has there been a greater need for clear and meaningful communication in the ever increasing noise and complexity.
At the PM Society Digital Interest Group (DIG), we set out to explore the role of AI in pharma marketing—not just by discussing it but by using AI to help write the very articles we were producing. This was far more than a writing exercise; it was an experiment in collaboration between human expertise and machine intelligence.
The Pharmaceutical Marketing Impact and Innovation (PMi) Awards, celebrating impact and innovation in pharmaceutical marketing and healthcare communications, launch on…
21GRAMS and Havas Lynx win big AstraZeneca and UCB top client leader board The 39th PM Society Awards, supported by…
The PM Society Diversity Interest Group have dived into the 2024 diversity survey results showing that ageism is still being experienced in our industry.
The PM Society Digital Interest Group are pleased to share an article that challenges how effective our industries approach is to marketing.
Artificial intelligence is reshaping the pharmaceutical industry, offering powerful solutions to improve marketing, medical affairs, and operations. This article provides actionable insights for pharmaceutical professionals, through real-life examples.
The Industry Agency Relationships Interest Group has been working on a guide to procurement in pharma marketing and communications for over a year.
As 2024 draws to a close, it’s a great opportunity to reflect on our great work and achievements over the year.
